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SARS-CoV-2 has become a pandemic in the world. The virus binds to the Angiotensin-
Converting Enzyme 2 (ACE2) receptor, which is found in epithelial cells such as in the lungs, to 
generate the pathology of COVID-19. It is essential to analyze the characteristics of ACE2 in 
understanding the development of the disease and study potential new drugs. The analysis was carried 
out using computer simulations to speed up protein analysis that utilized Artificial Intelligence 
technology, databases, and big data. Homology modeling is a method to exhibit homologous of protein 
families, hence the model and arrangement of protein sequences modeled are established. This 
research aims to determine the possibility of mutations in ACE2 by performing the mutation 
prediction. The result shows reliable homologous modeling with the score of GA341, MPQS, Z-
DOPE, and TSVMod NO35 were 1; 1.28252; -0.47; and 0.793, respectively. Moreover, Gene 
Ontology (GO) analysis describes that ACE2 has a molecular transport function in cells while there 
are no mutations found occurred in ACE2 analyzed using SIFT and PROVEAN. 
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SARS-CoV-2 is considered to be a new Betacoronavirus that infects humans (Lu et al., 2020). 
Phylogenetic analysis of the SARS-CoV-2 genome shows that the virus is closely related (88% 
similarity) to two coronaviruses that resemble severe acute respiratory syndrome (SARS) from bats 
collected in 2018 in eastern China (bat- SL-CoVZC45 and bat-SL-CoVZXC21) and are genetically 
different from SARS-CoV (approximately 79% similarity) and MERS-CoV (Lu et al., 2020). The 
coronavirus originated from bats (Rhinolophus affinis) from Yunnan Province, with 96.2% similarity 
in genomic sequence identities (Zhou et al., 2020). 
The virus that causes COVID-19 enters through the ACE2 receptor pathway (Wan et al., 2020). 
ACE2 is found in alveolar type II epithelial cells, which are receptors for the SARS-COV2 virus (Zhao 
et al., 2020). To speed up the analysis of virus proteins, computational methods are used. The 
computational method is able to simulate a protein, drug, receptor with the help of a computer. The use 
of computation in the field of drug development is a new trend in drug discovery using Artificial 
Intelligence (AI), databases, and big data, thus helping to understand the properties of a compound 
much more quickly and effectively in screening new drug candidates (Idakwo et al., 2018). 
The hinge-bending motion at the transmembrane helix does not change the shape of the ACE2 
homodimer or Angiotensin-Converting Enzyme 2-Receptor Binding Domain (ACE2-RBD). This 
sterically flexible shape makes the spike trimer binding change its conformation. These changes 
indicate that ACE2 affects the opening of glycoproteins to affect the increase in the number of 
infections (Barros et al., 2021). The N82 residue in ACE2 facilitates contact with the SARS-CoV-2 
protein in humans (Luan et al., 2020)  
There is a salt bridge on Lys417 of the SARS COV 2 protein and Asp30 of ACE2, three 
hydrogen bonds On Tyr449, Gln493, and Gln498 of SARS CoV 2, and Asp38, Glu35, and Lys353 of 
ACE2 (Ali and Vijayan, 2020). D614G mutation increases binding efficiency to ACE2. The trimer in 
SARS-S exhibits an open conformation, thereby conferring greater contractility on the receptor 
binding (RBD) that interacts explicitly with ACE2 (Ozono et al., 2021). 
Homology modeling is a method based on observations showing that all protein family 
members have the same fold shape. The use of this method relies on a homologous protein structure, 
where the protein structure has been determined experimentally (template) and allows the creation of a 
model starting from the protein sequence to be modeled (target). It is possible to observe the structural 
changes of each ACE2 variant that interacts with the SARS-COV-2 (Hussain et al., 2020). It can see 
possible binding stability and essential interactions with viruses (Ali and Vijayan, 2020). The resulting 
model from homology modeling can be used for ligand docking, macromolecular docking, ligand 
design, and studying catalytic mechanisms (Webb et al., 2014). It is hoped that the computational 
method will find out the active side of specific viral proteins so that it will help in the search for drugs 
and vaccines for COVID-19. With the help of computation, mutations can also be predicted, such as 
changes in amino acid substitutions, physical properties of proteins, insertions, and deletions of amino 
acids.  
 
MATERIALS AND METHODS 
Materials 
The research material is used a sequence of Angiotensin-converting enzyme 2 (ACE2) from 
humans with the Uniprot® database code (ID Q695T7). It is full-length human ACE2, in the presence 
of a neutral amino acid transporter B0AT1. The software is used UCSF Chimera 1.15®. It has 
forcefield tools to perform molecular dynamic analysis such as Parameters for solvation energy 
(PARSE), AMBER, SWANSON, CHARMM, PEOEPB, and TYL06. In addition, web servers are 
used, such as NCBI®, BLAST, MolProbity®, Clustal Omega®, Cofactor®, Sorting Intolerant From 
Tolerant (SIFT®), Protein Variation Effect Analyzer (PROVEAN), Modeler® and Swiss-Model®. 
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It is utilized because it opens access and user-friendly. The modeler has a script file so that parameters 
can be adjusted. 
 
Methods 
Homology modeling using swiss model 
The preparation of the ACE2 enzyme sequence was carried out by searching the Homo sapiens 
(Human) ACE2 enzyme sequence in the Uniprot® database. Data from Uniprot is then inputted, and a 
model is made. Furthermore, validation was carried out using Molprobity® and analyzed in 3D using 
UCSF Chimera. 
 
Homology modeling using modeller 
Making enzyme models using the homology modeling method begins with a search for 
templates with the help of the NCBI® web server www.ncbi.nlm.nih.gov/.  An alignment search is 
carried out using The Basic Local Alignment Search Tool (BLAST) to find templates that are similar 
to Homo sapiens ACE2 sequence. Then the blastp is input by entering the FASTA Sequence to find 
out the similarities of the sequences. Obtained five templates that have similarities, then the FASTA 
sequence is downloaded. After that, Multiple Sequence Alignment is carried out using Clustal Omega 
https://www.ebi.ac.uk/Tools/msa/clustalo/  then the Align is downloaded, then analyzed using the 
Modeler https://modbase.compbio.ucsf.edu/modweb/  and analyzed the 3D form using UCSF 
Chimera. 
 
Prediction analysis of ligand binding site, gene ontology and enzyme commission using cofactor 
Protein data from the Data Bank with code 6M17 was uploaded at 
https://zhanglab.ccmb.med.umich.edu/COFACTOR/ then analyzed the ligand-binding site and gene 
ontology. 
 
Prediction of Mutations from ACE2 
Mutation prediction analysis with interset G8790A using the Sorting Intolerant From Tolerant 
(SIFT) application https://sift.bii.a-star.edu.sg/ and also used the PROVEAN application 
http://provean.jcvi.org/seq_submit.php. Sequence sequences in Fasta format are inputted into SIFT 
Sequences and PROVEAN. 
 
RESULTS AND DISCUSSION 
Homology modeling using swiss model 
Setup the ACE2 sequence by inputting the Uniprot ID code file format Q695T7). Obtained 
amino acid sequence which is used to find the template in making ACE2 model. The sequence of the 
ACE2 sequence can be seen in Figure 1. This method is used to generate a previously unknown 
protein structure by "fitting" its sequence (target) into a known structure (template), with a certain 
degree of sequence homology (at least 30%) between the target and template (Sensoy et al., 2017). It is 
accurate for making structural models of proteins (Skariyachan and Garka, 2018). 
 
                ISSN: 2088 4559; e-ISSN: 2477 0256 








Figure 1. Sequence of ACE2 sufferers of COVID-19 
 
ACE2's 3D structure prediction uses the Swiss-Model webserver to obtain accurate modeling. In 
the Homology Modeling study, several steps must be taken, (1) It is identifying the target sequence 
using BLAST,  (2) Perform Sequence Alignment, (3) Correct the alignment order, (4) Identify the 
backbone, (5) Loop modeling (6) Sidechain modeling using rotamer data, (7) Optimization of the 
model using energy minimization data, (8) Stereochemical model validation using the Ramachandran 
plot (Gromiha et al., 2018). 
A template with swiss-model analysis, namely PDB 6M17 and 6M18. These two proteins are 
specific structures for identifying SARS-CoV-2 using the human ACE2 standard (Yan et al., 2020), 
which has 100 percent similarity. The tyrosinase enzyme modeling using the Swiss-Model® 
webserver was carried out automatically (automated mode). 
Sequence alignment or better known as sequence alignment, is intended to determine the 
similarity between the target amino acid sequence and the template amino acid sequence. Sequence 
alignment between the ACE2 target and the template (PDB ID 6M17 and 6M18) was carried out using 
the assistance of the Swiss-Model® web server. The results of the alignment of the sequences with the 
Swiss-Model can be seen in Figure 2 and Figure 3. 
The modeling of the ACE2 enzyme using the Swiss-Model is done by inputting data so that a 
3D protein form is obtained. The results are obtained automatically by transferring atomic coordinates 
and aligning them with the target template. SWISS-MODEL relies on the OpenStructure 
computational structural biology framework (Biasini et al., 2013) and the database from Promod3 
(Waterhouse et al., 2018). Swiss-Model® ACE2 3D model prediction assessment generated by using 
the QMEAN rating function. The QMEAN (Qualitative Model Energy Analysis) assessment function 
is a function that describes the geometric structure of proteins (Benkert et al., 2008). From the research 
data, the QMEAN score data obtained from the modeling is -4.50 for the 6M17 model and -4.92 for 
the 6M18, where the score shows the results of the modeling quality with low quality. The QMEAN 
score value ≤ −4.0 indicates that the model made has low quality. 
Model Evaluation and Optimization The evaluation carried out on the ACE2 model from the 
results of homology modeling includes evaluating the stereochemical properties and spatial properties 
of the model. Evaluation of the stereochemical properties of the model was carried out using the Swiss 
Model web server by analyzing the Ramachandran and Molprobity® plots to determine the acquisition 
of the clash score and molprobity scores from the model.  
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Figure 2. Model-Template Alignment 6M17 
 
     
 
Figure 3. Model-template alignment 6M18 
 
The Ramachandran plot is a two-dimensional graph depicting amino acid residues in the 
enzyme structure, where the angles φ (phi) as the x-axis and ψ (psi) as the y-axis are divided into four 
quadrants, the angular values of the spectrum from each axis range from −180° to +180° (Choudhuri, 
2014). It is plot visualizes the do-and-not areas in the plane of dihedral angles. The quality of the 
homolog is poor if many forbidden regions are found (Wiltgen, 2018). Visualization of the results of 
the Ramachandran plot can be seen in Figure 4. 
The evaluation of contacts between atoms is based on the clashscore assessment. Evaluation 
results can be seen in Table 1. Clashscore is the steric number that overlaps per 1000 atoms. The best 
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clashscore value is <100. It has met the standard value in homologous modeling. The molprobity score 
is a combination of clashscore, percentage forbidden regions, and the percentage of bad rotamer, 
which reflects the value of the crystallographic resolution appropriate for the model. Judging from the 
Molprobity score, the data model has met the standard because it is <84. 
 
Table 1. Evaluation of homology modeling using the swiss model 
Model Clashscore 
Plot Ramachandran Skor 
MolProbity 
 
Favored Regions Outlier 
6M17 0.94 93.37% 0.50% 1.21 
6M18 10.32 91.19% 1.11% 2.43 
 
Both models do not meet the standard value of the standard value (> 98%). The two models' 
outlier value does not enter the standard criteria, namely <0.05%.  Low-quality result of Swiss Model 
because steric hindrance between the Cβ side chain and the central chain atoms.  
 
 
                                               Figure 4. Ramachandran plot of ACE2 using the Swiss-model 
  
Homology modeling using modelers 
The search for templates was carried out using the assistance of the NCBI® BLAST web server 
to find the protein structure that has the highest sequence similarity to the target amino acid sequence, 
which has been known experimentally in 3D structure. One of the tools that NCBI has that is 
commonly used to find similar sequences in the BLAST (Basic Local Alignment Search Tool), which 
looks for similarities in templates with the highest percentage of identity.  
 








6M17_A 99% 0 100% Chain A. ACE2 (Human) 
4XPH_A 84% 2.00E-79 43.65% Chain A. Transporter (Drosophila melanogaster) 
4XPT_A 84% 2.00E-79 43.51% Chain A. Dopamine (Drosophila melanogaster) 
4XNX_A 84% 2.00E-78 43.32% Chain A. transporter (Drosophila melanogaster) 
4XP5_A 84% 3.00E-78 43.32% Chain A. Dopamine Transporter, Isoform B 
(Drosophila melanogaster) 
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The results of the sequence analysis using BLAST can be seen in Table 2, selected 5 sequences 
that have a similarity> 43%—followed by multiple sequence alignment using Clustal Omega. The 
percentage of similarity in identity is shown by the Query Cover, which is input into BLAST. A good 
sequence is one that has a similarity sequence> 30%. The Three-dimensional space (3D) form of 
modeling can be seen in Figure 5. It was obtained three 3D models. Modeler software brought one 
model with the protein data bank code 6M17. The Swiss model software received two 3-dimensional 
forms, namely the protein data bank code 6M17 and 6M18 
 
 
Figure 5. Model 3D ACE2 Homologous 
 
The results of the thread sequence and the model evaluation values using a modeler can be seen 
in Table 3. Model evaluation of the model is carried out, including the assessment of E-Value, GA341, 
MPQS, z-DOPE, and TSVMod NO35. The results obtained are included in the criteria (reliable). 
 















E-Value is a parameter used to compare the size form's suitability between the design and the 
actual shape of the score database. The standard score is <0.0001. GA341 is a value that can be trusted 
from statistical modeling with a standard value of ≥0.7. The MPQS is a composite score consisting of 
the template sequence identity, z-Dope value, and GA341. Z-Dope is a value that describes the folds in 
the template model with criteria that meet the standards, namely <0 (Webb and Sali, 2016). TSVMod 
NO35 is an estimated value overlap with the standard value, namely ≥40%. From the evaluation of the 
data obtained, the homologous modeling above fulfills the standard criteria. 
 The ACE2 variant exhibits a similar binding affinity for the SARS-CoV-2 spike protein as 
observed in the structure of the wild-type ACE2 and SARS-CoV-2 spike protein complex. However, 
the ACE2 alleles, rs73635825 (S19P) and rs143936283 (E329G), show marked variations in their 
intermolecular interactions with viral spike proteins (Hussain et al., 2020). It has the strongest binding 
interaction. The earliest isolates of SARS-CoV-2 were surprisingly well adapted to human ACE2, 
potentially explaining its rapid transmission (Piplani et al., 2020). Twenty residues interact with 
proteins and can bind to ACE2, of which five residues (Val445, Thr478, Gly485, Phe490, and 
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Ser494). The interaction between ACE2 and the tertiary structure of the protein is different from that 
of ACE2 and the RBD protein monomer (Sakkiah et al., 2021). 
 
Analysis of ligand binding site prediction, gene ontology (GO) using cofactor 
Analysis of the Predicted Gene ontology and predicted binding side using the Cofactor can be 
seen in Table 4. Cofactor is an application that can predict the structure and function of proteins. 
Cofactor can categorize proteins such as Gene Ontology, Enzyme Commission, and Ligand-Binding 
sites from analogs and template homologs (Zhang et al., 2017). 
 










Transporter Activity Transport Cell Part 
Cscore 0.99 0.97 1 
GO Term GO:0005215 GO:0006810 GO:0044464 
  
Gene ontology (GO) is a framework and concept for describing genes' function in all organisms. 
Gene ontology facilitates computational interpretation of biological systems. GO Term is a unique 
code to facilitate and classify gene ontologies (Dessimoz and Škunca, 2017). In terms of gene 
ontology, ACE2 has biological and molecular functions as a transporter activity. ACE2 is involved in 
the movement of molecules and ions from outside to into the cell or vice versa. It is essential to know 
the ligand and binding site in analyzing protein because this is the place where the drug will attach 
later. This study predicts ligand and binding sites, the results of which can be seen in Table 5.  
Cs Score is a value in the range 0-1, the closer to the value 1, the more similar to the physical-
chemical properties of the protein with the database. The potential Ligand is Leucine with predicted 
binding site residues number 49, 51, 52, 53, 125, 129, 277, 278, 280, 283, 431, 435.  Cofactor was 
predicted ligand and binding site by collecting binding site data and mapping it from the query. The 
ligands originating from the template are placed in the query structure using the query matrix and the 
template binding site. It was calculated with Monte Carlo then compute the ligand pose to figure the 
motion and rotation of the atoms. Grouping ligands and their superposition obtain the final ligand into 
queries with a cut off of 8Å (Zhang et al., 2017). 
 




Score Ligand Name Predicted binding site residue 
3gjcB 0.28 Leucine 49,51,52,53,125,129,277,278,280,283,431,435 
3f4jA 0.15 Sodium Cation 49,50,51,53,54,278,310,314 
3gwwA 0.12 Fluoxetine 52,53,57,61,129,132,277,395,396,483,486 
3gwuA 0.12 Sertraline 56,57,129,277,395,396,482,486,491 
2qjuA 0.12 Desipramine 52,56,57,62,277,394,395 
 
Prediction of Mutations from ACE2 
Prediction of mutations using SIFT obtained ACE2 had not mutations. The mutations that were 
chosen to be compared were interset G8790A. G8790A is a gene that has a mutation in ACE2 
hypertensive patients (Li, 2012). It was able to predict amino acid substitution that affects protein 
function based on sequence homology and amino acid physical properties (Sim et al., 2012). Amino 
acid position was obtained from 1 to 634. Mutation analysis was also carried out using the PROVEAN 
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application; there were no mutations from the results. PROVEAN is a software that can predict amino 
acid substitution or indel that affects the biological function of a protein. PROVEAN was able to filter 
sequence variants on proteins (Choi and Chan, 2015). The subsequent significant study is molecular 
dynamics simulation to explain the interaction between RBD and ACE2 using NAMD and 
GROMACS. Free energy analysis should be carried out using the Molecular Mechanics Poisson-




Data Bank Protein Homologous Modeling shows the ID ACE2 protein data bank, namely 6M17 
and 6M18. Modeling using a Modeler is included in the Reliable criteria where the modeling results 
can be accepted. From the Gene Ontology analysis, ACE2 has a function as a transport molecule in 
cells. The result of ACE2 ligand prediction is Leucine with Predicted Binding Site Residue, namely 
49,51,52,53,125,129,277,278,280,283,431,435. From the prediction of mutations using SIFT and 
PROVEAN, there were no mutations in ACE2. 
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